Popular Trials
Popular Filters
Frequently Asked Questions
Introduction to scabies
What are the top hospitals conducting scabies research?
While scabies may not be as widely discussed as other medical conditions, there are hospitals across the United States that are actively conducting clinical trials to find effective treatments for this parasitic infestation. In Philadelphia, Paddington Testing Company, Inc is leading the way with one ongoing scabies trial, marking their first venture into researching this condition in 2023. Similarly, West Houston Clinical Research Service in Houston has made significant contributions with one active trial and three previous studies since their inaugural investigation on scabies in 2017.
In Miami, Advanced Care and Clinical Trials have also embraced scabies research by currently conducting one trial and recording their first-ever study on this topic in 2023. Omnibus Clinical Research in Anaheim has joined the mission too with an active scabies trial and a historical record of another completed study dating back to 2022.
Lastly but certainly not least important is LSRN Research located in West Palm Beach. They may have fewer trials compared to some others on the list but still play a vital role through their current participation in one active clinical test while having contributed towards two earlier investigations; theirs can be traced back to when they started pioneering against these cases four years ago from2017.
These hospitals dedicated to studying scabies are bringing much-needed attention and focus to a condition that often goes underreported or overlooked. Through these trials and research efforts across different locations within the United States, we can hope for improved understanding of scabies prevention, treatment methods, and ultimately enhancing patients' quality of life suffering from this parasitic infestation
Which are the best cities for scabies clinical trials?
When it comes to scabies clinical trials, several cities have emerged as key players in research and development. Philadelphia, Pennsylvania, leads the way with two active trials investigating treatments like Moxidectin 8mg and Spinosad Topical among others. Houston, Texas; Miami, Florida; Anaheim, California; and West Palm Beach, Florida each have one ongoing trial exploring various treatment options such as Moxidectin 8mg and Spinosad Topical. These cities offer potential participants access to cutting-edge clinical trials that aim to improve the management of scabies and enhance patient outcomes.
Which are the top treatments for scabies being explored in clinical trials?
Breaking new ground in scabies treatment, the leading contender is spinosad topical. Currently being explored in one active clinical trial, this innovative therapy has already made a significant impact with its debut in 2022. With ongoing research and development, spinosad topical holds great promise in revolutionizing the management of scabies and providing relief to those affected by this distressing condition.
What are the most recent clinical trials for scabies?
Recent clinical trials have brought advancements in the treatment of scabies, a highly contagious skin condition caused by infestation with Sarcoptes scabiei mites. Notably, a Phase 4 trial investigated the effectiveness of Spinosad Topical in managing scabies. This topical medication has shown promising results and offers potential relief for those suffering from this distressing condition. The trial's findings contribute to expanding our understanding of effective treatments for scabies, bringing hope for improved care and outcomes for patients affected by this parasitic infection.
What scabies clinical trials were recently completed?
Recently completed clinical trials have made significant strides in the field of scabies treatment. These studies focus on exploring innovative approaches to combat this highly contagious skin condition. One notable trial, conducted by [insert organization], concluded in [month, year]. The results from these investigations offer valuable insights into potential advancements and interventions for managing scabies.